EcoDrugPlus

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSODEG00000005211
Gene Symbol: GUCY1B1
3 Cross references
209 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class A Member 1

Ensembl ID : ENSODEG00000002636
Gene Symbol: HSP90AA1
2 Cross references
203 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSODEG00000009854
Gene Symbol: HRH2
3 Cross references
249 Possible Orthologues:

Histamine Receptor H3

Ensembl ID : ENSODEG00000003961
Gene Symbol: HRH3
3 Cross references
117 Possible Orthologues:

Histamine Receptor H4

Ensembl ID : ENSODEG00000004953
Gene Symbol: HRH4
3 Cross references
105 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSODEG00000003773
Gene Symbol: HDAC1
2 Cross references
256 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSODEG00000000226
Gene Symbol: HDAC11
1 Cross references
197 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSODEG00000000828
Gene Symbol: HDAC2
2 Cross references
201 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSODEG00000013234
Gene Symbol: HDAC3
3 Cross references
156 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSODEG00000018114
Gene Symbol: HDAC5
3 Cross references
195 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSODEG00000003964
Gene Symbol: HDAC7
3 Cross references
260 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSODEG00000002146
Gene Symbol: HDAC8
1 Cross references
201 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).